Received Apr 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 4 | U8372AA | IM / LL |
Patient guardian consented for DTap, however Vaxelis was given instead. Patient monitored for over 20 minutes post vaccination. No adverse reactions occured.
n/a
n/a
n/a
n/a